Central Pharmaceutical JSC No. 3

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DP36
VND
63,000.00
200 (0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Central Pharmaceutical JSC No. 3
Traphaco JSC

Why is Central Pharmaceutical JSC No. 3 ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Central Pharmaceutical JSC No. 3 should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
1.60%
EBIT Growth (5y)
7.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.88
Tax Ratio
20.24%
Dividend Payout Ratio
53.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
68.54%
ROE (avg)
26.75%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
2.20
EV to EBIT
5.18
EV to EBITDA
4.90
EV to Capital Employed
5.90
EV to Sales
1.85
PEG Ratio
1.28
Dividend Yield
5.75%
ROCE (Latest)
113.87%
ROE (Latest)
24.96%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
OPERATING CASH FLOW(Y)

Highest at VND 252,867.46 MM

CASH AND EQV(HY)

Highest at VND 888,183.79 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 3.02 times

DIVIDEND PER SHARE(HY)

Highest at VND 9.71

NET SALES(Q)

Highest at VND 131,632.48 MM

OPERATING PROFIT(Q)

Highest at VND 82,911.67 MM

OPERATING PROFIT MARGIN(Q)

Highest at 62.99 %

PRE-TAX PROFIT(Q)

Highest at VND 93,298.39 MM

NET PROFIT(Q)

Highest at VND 74,574.35 MM

-8What is not working for the Company
INTEREST(Q)

At VND 230.15 MM has Grown at 35.73%

DIVIDEND PAYOUT RATIO(Y)

Lowest at 115.31%

EPS(Q)

Lowest at VND 0

Here's what is working for Central Pharmaceutical JSC No. 3

Pre-Tax Profit
At VND 93,298.39 MM has Grown at 130.02%
over average net sales of the previous four periods of VND 40,560.62 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (VND MM)

Net Profit
At VND 74,574.35 MM has Grown at 131.1%
over average net sales of the previous four periods of VND 32,269.9 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (VND MM)

Operating Cash Flow
Highest at VND 252,867.46 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (VND MM)

Net Sales
Highest at VND 131,632.48 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (VND MM)

Net Sales
At VND 131,632.48 MM has Grown at 24.61%
over average net sales of the previous four periods of VND 105,637.37 MM
MOJO Watch
Near term sales trend is positive

Net Sales (VND MM)

Operating Profit
Highest at VND 82,911.67 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (VND MM)

Operating Profit Margin
Highest at 62.99 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at VND 93,298.39 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (VND MM)

Net Profit
Highest at VND 74,574.35 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (VND MM)

Cash and Eqv
Highest at VND 888,183.79 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 3.02 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Dividend per share
Highest at VND 9.71
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (VND)

Here's what is not working for Central Pharmaceutical JSC No. 3

Interest
At VND 230.15 MM has Grown at 35.73%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

EPS
Lowest at VND 0
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (VND)

Dividend Payout Ratio
Lowest at 115.31%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)